M1 Kliniken AG (FRA:M12)

Market Cap	359.60M +29.5%
Revenue (ttm)	257.36M -27.5%
Net Income	20.23M +14.0%
EPS	1.08 +12.6%
Shares Out	n/a
PE Ratio	18.02
Forward PE	n/a
Dividend	1.20 (6.15%)
Ex-Dividend Date	Jul 9, 2026

Volume	350
Open	19.52
Previous Close	19.88
Day's Range	19.52 - 19.52
52-Week Range	13.78 - 21.25
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 10, 2026

About M1 Kliniken AG

M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, Croatia, Hungary, Bulgaria, and Romania. It operates through Beauty and Trade segments. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segment also manages a private clinic for plastic and aesthetic surgery; a...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2007
• Employees: 280
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: M12

Financial Performance

In 2025, M1 Kliniken AG's revenue was 364.30 million, an increase of 7.40% compared to the previous year's 339.18 million. Earnings were 22.13 million, an increase of 38.17%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error